Studies of tumors from African American, European American, and Kenyan patients aim to illuminate breast cancer biology across population groups.
All in National Cancer Institute
Studies of tumors from African American, European American, and Kenyan patients aim to illuminate breast cancer biology across population groups.
Molecular signatures of canine osteosarcoma prognosis could also predict clinical outcomes for human osteosarcomas.
Cells that are preparing to divide can return to a resting state if they lose growth signals, even after they have passed what was thought to be a point of no return.
NCI database links extensive drug activity data to detailed molecular information about the cancer cell lines in which those drugs have been tested.
The final act of a dying cancer cell may be to spur the growth of other cancer cells.
Breast cancer cells undergo dangerous reprogramming within passageways that connect tumors to the bloodstream.
Artificial intelligence untangles the cellular signals that matter for anticancer immunity.
A potential new marker for immunotherapy response could help guide treatment decisions.
Elusive tumor-targeting T cells share a telltale gene activity signature.